Exhibit 10.1


 


Subscription
Agreement


 


THE
SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR THE SECURITIES LAWS OF ANY STATE OR ANY OTHER JURISDICTION.
THERE ARE FURTHER RESTRICTIONS ON THE TRANSFERABILITY OF THE SECURITIES DESCRIBED HEREIN.


 


THE
PURCHASE OF THE SECURITIES INVOLVES A HIGH DEGREE OF RISK AND SHOULD BE CONSIDERED ONLY BY PERSONS WHO CAN BEAR THE RISK OF THE
LOSS OF THEIR ENTIRE INVESTMENT.


 


HEALTHLYNKED
CORP.


1726
Medical Blvd., Suite 101, 


Naples,
Florida 34110


 


Article
I 


 


Ladies
and Gentlemen:


 


The
undersigned understands that HEALTHLYNKED CORP., a corporation organized under the laws of Nevada (the “Company”),
is offering an aggregate of _________ shares of its common stock, par value $0.0001 per share (the “Securities”)
in a private placement. The undersigned further understands that the offering is being made without registration of the Securities
under the Securities Act of 1933, as amended (the “Securities Act”), or any securities law of any state of the
United States or of any other jurisdiction, and is being made only to “accredited investors” (as defined in Rule 501
of Regulation D under the Securities Act).


 


1.            Subscription. Subject to the terms and conditions hereof, the undersigned hereby irrevocably subscribes for the Securities
set forth in Appendix A hereto for the aggregate purchase price set forth in Appendix A, which is payable as described in Section
4 hereof. The undersigned acknowledges that the Securities will be subject to restrictions on transfer as set forth in this
subscription agreement (the “Subscription Agreement”).


 


2.            Acceptance of Subscription and Issuance of Securities. It is understood and agreed that the Company shall have the sole
right, at its complete discretion, to accept or reject this subscription, in whole or in part, for any reason and that the same
shall be deemed to be accepted by the Company only when it is signed by a duly authorized officer of the Company and delivered
to the undersigned at the Closing referred to in Section 3 hereof. Subscriptions need not be accepted in the order received,
and the Securities may be allocated among subscribers. Notwithstanding anything in this Subscription Agreement to the contrary,
the Company shall have no obligation to issue any of the Securities to any person who is a resident of a jurisdiction in which
the issuance of Securities to such person would constitute a violation of the securities, “blue sky” or other similar
laws of such jurisdiction (collectively referred to as the “State Securities Laws”).


 






     

     


    

 


3.            The Closing. The closing of the purchase and sale of the Securities (the “Closing”) shall take place at
the offices of the Company, at 10:00 a.m. on ___________, or at such other time and place as the Company may designate by notice
to the undersigned.


 


4.            Payment for Securities. Payment for the Securities shall be received by the Company from the undersigned by wire transfer
of immediately available funds or other means approved by the Company at or prior to the Closing, in the amount as set forth in
Appendix A hereto. The Company shall deliver certificates representing the Securities to the undersigned at the Closing bearing
an appropriate legend referring to the fact that the Securities were sold in reliance upon an exemption from registration under
the Securities Act.


 


5.            Representations and Warranties of the Company. As of the Closing, the Company represents and warrants that:


 


(a)          The Company is duly formed and validly existing under the laws of Nevada, with full power and authority to conduct its business
as it is currently being conducted and to own its assets; and has secured any other authorizations, approvals, permits and orders
required by law for the conduct by the Company of its business as it is currently being conducted.


 


(b)          The Company has all requisite to issue and sell the Securities, enter into this Subscription Agreement and to perform all the
obligations required to be performed by it hereunder, and such purchase will not contravene any law, rule or regulation binding
on the Company.


 


(c)          The Securities have been duly authorized and, when issued, delivered and paid for in the manner set forth in this Subscription
Agreement, will be validly issued, fully paid and nonassessable.


 


(d)          Except as a result of the purchase and sale of the Securities and as disclosed in the SEC Reports, there are no outstanding options,
warrants, scrip rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities, rights or
obligations convertible into or exercisable or exchangeable for, or giving any Person any right to subscribe for or acquire, any
shares of common stock, or contracts, commitments, understandings or arrangements by which the Company is or may become bound
to issue additional shares of common stock or securities convertible or exercisable into common stock (the “Common Stock
Equivalents”). 


 






    	 	2	 



     


    

 


(e)          The Company has filed all reports, schedules, forms, statements and other documents required to be filed by the Company under
the Securities Act and the Exchange Act of 1934, as amended (the “Exchange Act”), including pursuant to Section 13(a) or
15(d) thereof, for the two years preceding the date hereof (or such shorter period as the Company was required by law or
regulation to file such material) (the foregoing materials, including the exhibits thereto and documents incorporated by reference
therein, and the Company’s registration statements on Form S-1 and Form S-8, being collectively referred to herein as the
“SEC Reports”) on a timely basis or has received a valid extension of such time of filing and has filed any
such SEC Reports prior to the expiration of any such extension.  As of their respective dates, the SEC Reports complied in
all material respects with the requirements of the Securities Act and the Exchange Act, as applicable, and none of the SEC Reports,
when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein
or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.
The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting
requirements and the rules and regulations of the Securities and Exchange Commission (the “Commission”)
with respect thereto as in effect at the time of filing.  Such financial statements have been prepared in accordance with
United States generally accepted accounting principles applied on a consistent basis during the periods involved (“GAAP”),
except as may be otherwise specified in such financial statements or the notes thereto and except that unaudited financial statements
may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company
as of and for the dates thereof and the results of operations and cash flows for the periods then ended, subject, in the case
of unaudited statements, to normal, immaterial, year-end audit adjustments.


 


(f)           Since the date of the latest audited financial statements included within the SEC Reports, except as specifically disclosed in
a subsequent SEC Report filed prior to the date hereof, (i) there has been no event, occurrence or development that has had
or that could reasonably be expected to result in a Material Adverse Effect, (ii) the Company has not incurred any liabilities
(contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business
consistent with past practice and (B) liabilities not required to be reflected in the Company’s financial statements
pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered its method of accounting,
(iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased,
redeemed or made any agreements to purchase or redeem any shares of its capital stock and (v) the Company has not issued
any equity securities to any officer, director or Affiliate, except pursuant to existing Company stock option plans.  The
Company does not have pending before the Commission any request for confidential treatment of information.  “Material
Adverse Effect” means (i) a material adverse effect on the legality, validity or enforceability of this Subscription
Agreement, (ii) a material adverse effect on the results of operations, assets, business, prospects or condition (financial
or otherwise) of the Company and its subsidiaries, taken as a whole, or (iii) a material adverse effect on the Company’s
ability to perform in any material respect on a timely basis its obligations under this Subscription Agreement.


 






    	 	3	 



     


    

 


(g)          There is no action, suit, inquiry, notice of violation, proceeding or investigation pending or, to the knowledge of the Company,
threatened against or affecting the Company, any subsidiary or any of their respective properties before or by any court, arbitrator,
governmental or administrative agency or regulatory authority (federal, state, county, local or foreign) (collectively, an “Action”)
which adversely affects or challenges the legality, validity or enforceability of any of this Subscription Agreement or the Securities. 
Neither the Company nor any subsidiary, nor any director or officer thereof, is or has been the subject of any Action involving
a claim of violation of or liability under federal or state securities laws or a claim of breach of fiduciary duty.  There
has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the Commission involving
the Company or any current or former director or officer of the Company.  The Commission has not issued any stop order or
other order suspending the effectiveness of any registration statement filed by the Company or any Subsidiary under the Exchange
Act or the Securities Act.


 


6.            Representations and Warranties of the Undersigned. The undersigned hereby represents and warrants to and covenants with
the Company that:


 


(a)          General.


 


(i)          The undersigned has all requisite authority (and in the case of an individual, the capacity) to purchase the Securities, enter
into this Subscription Agreement and to perform all the obligations required to be performed by the undersigned hereunder, and
such purchase will not contravene any law, rule or regulation binding on the undersigned or any investment guideline or restriction
applicable to the undersigned.


 


(ii)         The undersigned is a resident of the state set forth on the signature page hereto and is not acquiring the Securities as a nominee
or agent or otherwise for any other person.


 


(iii)        The undersigned will comply with all applicable laws and regulations in effect in any jurisdiction in which the undersigned purchases
or sells Securities and obtain any consent, approval or permission required for such purchases or sales under the laws and regulations
of any jurisdiction to which the undersigned is subject or in which the undersigned makes such purchases or sales, and the Company
shall have no responsibility therefor.


 


(b)          Information Concerning the Company.


 


(i)          The undersigned has access to and carefully reviewed the Company’s SEC Reports and has had on opportunity for a reasonable
period of time prior to the date hereof to obtain additional information concerning the offering of the Securities, the Company,
and all other information to the extent the Company possesses such information or can acquire it without unreasonable effort or
expense.


 






    	 	4	 



     


    

 


(ii)         The undersigned understands and accepts that the purchase of the Securities involves various risks, including the risks outlined
in the SEC Reports and this Subscription Agreement. The undersigned represents that it is able to bear any loss associated with
an investment in the Securities.


 


(iii)        The undersigned confirms that it is not relying on any communication (written or oral) of the Company or any of its affiliates,
as investment advice or as a recommendation to purchase the Securities. It is understood that information and explanations related
to the terms and conditions of the Securities provided by the Company or any of its affiliates shall not be considered investment
advice or a recommendation to purchase the Securities, and that neither the Company nor any of its affiliates is acting or has
acted as an advisor to the undersigned in deciding to invest in the Securities. The undersigned acknowledges that neither the
Company nor any of its affiliates has made any representation regarding the proper characterization of the Securities for purposes
of determining the undersigned’s authority to invest in the Securities.


 


(iv)        The undersigned is familiar with the business and financial condition and operations of the Company, all as generally described
in the SEC Reports. The undersigned has had access to such information concerning the Company and the Securities as it deems necessary
to enable it to make an informed investment decision concerning the purchase of the Securities.


 


(v)         The undersigned understands that, unless the undersigned notifies the Company in writing to the contrary at or before the Closing,
each of the undersigned’s representations and warranties contained in this Subscription Agreement will be deemed to have been
reaffirmed and confirmed as of the Closing, taking into account all information received by the undersigned.


 


(vi)        The undersigned acknowledges that the Company has the right in its sole and absolute discretion to abandon this private placement
at any time prior to the completion of the offering. This Subscription Agreement shall thereafter have no force or effect and
the Company shall return the previously paid subscription price of the Securities, without interest thereon, to the undersigned.


 


(vii)       The undersigned understands that no federal or state agency has passed upon the merits or risks of an investment in the Securities
or made any finding or determination concerning the fairness or advisability of this investment.


 


(c)          Non-reliance.


 


(i)          The undersigned represents that it is not relying on (and will not at any time rely on) any communication (written or oral) of
the Company, as investment advice or as a recommendation to purchase the Securities.


 






    	 	5	 



     


    

 


(ii)         The undersigned confirms that the Company has not (A) given any guarantee or representation as to the potential success, return,
effect or benefit (either legal, regulatory, tax, financial, accounting or otherwise) of an investment in the Securities or (B)
made any representation to the undersigned regarding the legality of an investment in the Securities under applicable legal investment
or similar laws or regulations. In deciding to purchase the Securities, the undersigned is not relying on the advice or recommendations
of the Company and the undersigned has made its own independent decision that the investment in the Securities is suitable and
appropriate for the undersigned.


 


(d)          Status of Undersigned.


 


(i)          The undersigned has such knowledge, skill and experience in business, financial and investment matters that the undersigned is
capable of evaluating the merits and risks of an investment in the Securities. With the assistance of the undersigned’s own professional
advisors, to the extent that the undersigned has deemed appropriate, the undersigned has made its own legal, tax, accounting and
financial evaluation of the merits and risks of an investment in the Securities and the consequences of this Subscription Agreement.
The undersigned has considered the suitability of the Securities as an investment in light of its own circumstances and financial
condition and the undersigned is able to bear the risks associated with an investment in the Securities and its authority to invest
in the Securities.


 


(ii)         The undersigned is an “accredited investor” as defined in Rule 501(a) under the Securities Act. The undersigned agrees
to furnish any additional information requested by the Company or any of its affiliates to assure compliance with applicable U.S.
federal and state securities laws in connection with the purchase and sale of the Securities. The undersigned acknowledges that
the undersigned has completed the Investor Questionnaire contained in Appendix B and that the information contained therein is
complete and accurate as of the date thereof and is hereby affirmed as of the date hereof. Any information that has been furnished
or that will be furnished by the undersigned to evidence its status as an accredited investor is accurate and complete, and does
not contain any misrepresentation or material omission.


 


(e)          Restrictions on Transfer or Sale of Securities. As applies to the Purchaser:


 


(i)          The undersigned is acquiring the Securities solely for the undersigned’s own beneficial account, for investment purposes,
and not with a view to, or for resale in connection with, any distribution of the Securities. The undersigned understands that
the Securities have not been registered under the Securities Act or any State Securities Laws by reason of specific exemptions
under the provisions thereof which depend in part upon the investment intent of the undersigned and of the other representations
made by the undersigned in this Subscription Agreement. The undersigned understands that the Company is relying upon the representations
and agreements contained in this Subscription Agreement (and any supplemental information) for the purpose of determining whether
this transaction meets the requirements for such exemptions.


 






    	 	6	 



     


    

 


(ii)         The undersigned understands that the Securities are “restricted securities” under applicable federal securities laws
and that the Securities Act and the rules of the Commission provide in substance that the undersigned may dispose of the Securities
only pursuant to an effective registration statement under the Securities Act or an exemption therefrom, and the undersigned understands
that the Company has no obligation or intention to register any of the Securities, or to take action so as to permit sales pursuant
to the Securities Act (including Rule 144 thereunder). Accordingly, the undersigned understands that under the Commission’s rules,
the undersigned may dispose of the Securities principally only in “private placements” which are exempt from registration
under the Securities Act, in which event the transferee will acquire “restricted securities” subject to the same limitations
as in the hands of the undersigned. Consequently, the undersigned understands that the undersigned must bear the economic risks
of the investment in the Securities for an indefinite period of time.


 


(iii)        The undersigned agrees: (A) that the undersigned will not sell, assign, pledge, give, transfer or otherwise dispose of the Securities
or any interest therein, or make any offer or attempt to do any of the foregoing, except pursuant to a registration of the Securities
under the Securities Act and all applicable State Securities Laws, or in a transaction which is exempt from the registration provisions
of the Securities Act and all applicable State Securities Laws; (B) that the certificates representing the Securities will bear
a legend making reference to the foregoing restrictions; and (C) that the Company and it affiliates shall not be required to give
effect to any purported transfer of such Securities except upon compliance with the foregoing restrictions.


 


(iv)        The undersigned acknowledges that neither the Company nor any other person offered to sell the Securities to it by means of any
form of general solicitation or advertising, including but not limited to: (A) any advertisement, article, notice or other communication
published in any newspaper, magazine or similar media or broadcast over television or radio or (B) any seminar or meeting whose
attendees were invited by any general solicitation or general advertising.


 


7.            Conditions to Obligations of the Undersigned and the Company. The obligations of the undersigned to purchase and pay for
the Securities specified in Appendix A and of the Company to sell the Securities are subject to the satisfaction at or prior to
the Closing of the following conditions precedent: the representations and warranties of the Company contained in Section 5
hereof and of the undersigned contained in Section 6 hereof shall be true and correct as of the Closing in all respects
with the same effect as though such representations and warranties had been made as of the Closing.


 






    	 	7	 



     


    

 


8.            Obligations Irrevocable. The obligations of the undersigned shall be irrevocable.


 


9.            Legend. The certificates representing the Securities sold pursuant to this Subscription Agreement will be imprinted with
a legend in substantially the following form:


 


“THE
SECURITIES EVIDENCED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES
ACT”), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. THE SECURITIES MAY NOT BE OFFERED, SOLD, PLEDGED OR OTHERWISE
TRANSFERRED EXCEPT (1) PURSUANT TO AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OR (2) PURSUANT TO AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE SECURITIES ACT, IN EACH CASE IN ACCORDANCE WITH ALL APPLICABLE STATE SECURITIES LAWS AND THE SECURITIES LAWS
OF OTHER JURISDICTIONS, AND IN THE CASE OF A TRANSACTION EXEMPT FROM REGISTRATION, UNLESS THE COMPANY HAS RECEIVED AN OPINION
OF COUNSEL REASONABLY SATISFACTORY TO IT THAT SUCH TRANSACTION DOES NOT REQUIRE REGISTRATION UNDER THE SECURITIES ACT AND SUCH
OTHER APPLICABLE LAWS.”


 


10.          Lock-Up of Securities. The undersigned will not, for a period commencing on the date hereof and ending six months thereafter,
(1) offer, pledge, sell, contract to sell, grant any option or contract to purchase, purchase any option or contract to sell,
or otherwise dispose of, directly or indirectly, any Securities of the Company purchased under this Subscription Agreement, (2)
enter into any swap or other arrangement that transfers to another, in whole or in part, any of the economic consequences of ownership
of such Securities, whether any such transaction described in clause (1) or (2) above is to be settled by delivery of such Securities,
in cash or otherwise.


 


11.          Waiver, Amendment. Neither this Subscription Agreement nor any provisions hereof shall be modified, changed, discharged
or terminated except by an instrument in writing, signed by the party against whom any waiver, change, discharge or termination
is sought.


 


12.          Assignability. Neither this Subscription Agreement nor any right, remedy, obligation or liability arising hereunder or
by reason hereof shall be assignable by either the Company or the undersigned without the prior written consent of the other party.


 


13.          Waiver of Jury Trial. THE UNDERSIGNED IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY WITH RESPECT TO ANY LEGAL PROCEEDING
ARISING OUT OF THE TRANSACTIONS CONTEMPLATED BY THIS SUBSCRIPTION AGREEMENT.


 






    	 	8	 



     


    

 


14.          Submission to Jurisdiction. With respect to any suit, action or proceeding relating to any offers, purchases or sales of
the Securities by the undersigned (“Proceedings”), the undersigned irrevocably submits to the jurisdiction of
the federal or state courts located in the Borough of Manhattan in New York City, which submission shall be exclusive unless none
of such courts has lawful jurisdiction over such Proceedings.


 


15.          Governing Law. This Subscription Agreement shall be governed by and construed in accordance with the laws of the State
of New York.


 


16.          Section and Other Headings. The section and other headings contained in this Subscription Agreement are for reference purposes
only and shall not affect the meaning or interpretation of this Subscription Agreement.


 


17.          Counterparts. This Subscription Agreement may be executed in any number of counterparts, each of which when so executed
and delivered shall be deemed to be an original and all of which together shall be deemed to be one and the same agreement.


 


18.          Notices. All notices and other communications provided for herein shall be in writing and shall be deemed to have been
duly given if delivered personally or sent by registered or certified mail, return receipt requested, postage prepaid to the following
addresses (or such other address as either party shall have specified by notice in writing to the other):


 


	If
    to the Company:	HealthLynked
        Corp.

        1726
Medical Blvd Suite 101, Naples,

        Florida 34110

        

        Facsimile:

        

        E-mail:

        

        Attention:Chief
        Financial Officer

	 	 
	with
    a copy to:	Sichenzia
        Ross Ference Kesner LLP

        

        Facsimile:212
        930 9725

        

        E-mail:
        gsichenzia@srfkllp.com

        

        Attention:Gregory
        Sichenzia

	 	 
	If
    to the Purchaser:	Facsimile:

        

        E-mail:

        

        Attention:

	 	 
	with
    a copy to:	Facsimile:

        E-mail:

        

        Attention:



 






    	 	9	 



     


    

 


19.          Binding Effect. The provisions of this Subscription Agreement shall be binding upon and accrue to the benefit of the parties
hereto and their respective heirs, legal representatives, successors and assigns.


 


20.          Entire Agreement. This Subscription Agreement constitutes the entire agreement and supersedes all prior and contemporaneous
agreements and understandings among the parties with respect to the subject matter hereof and thereof.


 


21.          Survival. All representations, warranties and covenants contained in this Subscription Agreement shall survive (i) the
acceptance of the subscription by the Company and the Closing, (ii) changes in the transactions, documents and instruments described
herein which are not material or which are to the benefit of the undersigned and (iii) the death or disability of the undersigned.


 


22.          Notification of Changes. The undersigned hereby covenants and agrees to notify the Company upon the occurrence of any event
prior to the closing of the purchase of the Securities pursuant to this Subscription Agreement which would cause any representation,
warranty, or covenant of the undersigned contained in this Subscription Agreement to be false or incorrect.


 


23.          Severability. If any term or provision of this Subscription Agreement is invalid, illegal or unenforceable in any jurisdiction,
such invalidity, illegality or unenforceability shall not affect any other term or provision of this Subscription Agreement or
invalidate or render unenforceable such term or provision in any other jurisdiction.


 


 


 


[SIGNATURE
PAGE FOLLOWS]


 






    	 	10	 



     


    

 


IN
WITNESS WHEREOF, the undersigned has executed this Subscription Agreement this ____ OF ___________, _________.


 


	PURCHASER
    (if an individual):	 	PURCHASER
    (if an entity):
	 	 	 	 	 
	By	                 	 	                    
		 	 	Legal
                                         Name of Entity 



	Name:	 	 	 
		 	 	By	            
	 	 	 	Name:

        
	 
	 	 	 	Title:	 


 


State/Country
of Domicile or Formation: ______________________________________


 


Aggregate
Subscription Amount:


US$_________________________________________


 


The
offer to purchase Securities as set forth above is confirmed and accepted by the Company as to __________ shares of common stock.


 


	 	HEALTHLYNKED CORP.
	 	 	 
	 	By:	                   
	 	Name:	 
	 	Title:	 


 






    	 	11	 



     


    

 


APPENDIX
A


 


Consideration
To Be Delivered


 


	Securities
    to Be Acquired	Aggregate
    Purchase Price to be Paid
	 	 
	_________
    shares of common stock	US$
    ___________   


 


 


12